Ruochan Chen Selected Research

Enhancer RNAs

1/2021

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruochan Chen Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 12/2014
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2016
5	Inflammation (Inflammations) 01/2022 - 11/2013
4	Hepatitis B 01/2021 - 04/2016
4	Infections 01/2021 - 04/2016
4	Carcinogenesis 01/2021 - 11/2013
2	Liver Diseases (Liver Disease) 01/2021 - 11/2013
2	Chronic Hepatitis B 01/2021 - 01/2021
2	Sepsis (Septicemia) 01/2019 - 01/2019
2	Hypoxia (Hypoxemia) 01/2018 - 01/2016
2	Pancreatitis 01/2016 - 04/2014
2	Necrosis 03/2015 - 04/2014
1	Hepatic Encephalopathy 01/2021
1	COVID-19 12/2020
1	Human Influenza (Influenza) 03/2019
1	Escherichia coli Infections 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Fibrosarcoma 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2014
1	Immune System Diseases (Immune Disorders) 12/2014
1	Communicable Diseases (Infectious Diseases) 12/2014
1	Ischemia 12/2014
1	Edema (Dropsy) 04/2014
1	Fibrosis (Cirrhosis) 11/2013
1	Autoimmune Diseases (Autoimmune Disease) 11/2013

Drug/Important Bio-Agent (IBA)

7	HMGB1 Protein (HMG1)IBA 01/2022 - 11/2013
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2020
3	Hepatitis B e AntigensIBA 01/2021 - 04/2016
3	InflammasomesIBA 01/2019 - 01/2016
2	tenofovir alafenamideIBA 01/2021 - 01/2021
2	Long Noncoding RNAIBA 01/2020 - 12/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 09/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 01/2016
2	CeruletideIBA 01/2016 - 04/2014
2	Arginine (L-Arginine)FDA Link 01/2016 - 04/2014
2	Nucleosomes (Nucleosome)IBA 01/2016 - 04/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015 - 04/2014
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Enhancer RNAsIBA 01/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2021
1	FumaratesIBA 01/2021
1	Pharmaceutical PreparationsIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Oseltamivir (Tamiflu)FDA Link 03/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2018
1	Circular RNAIBA 01/2018
1	GA-Binding Protein Transcription FactorIBA 01/2018
1	Neutralizing AntibodiesIBA 09/2016
1	Heparin (Liquaemin)FDA LinkGeneric 09/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2016
1	ChemokinesIBA 09/2016
1	Histones (Histone)IBA 09/2016
1	hepatitis B hyperimmune globulinIBA 04/2016
1	Antiviral Agents (Antivirals)IBA 04/2016
1	NucleotidesIBA 04/2016
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 04/2016
1	NucleosidesIBA 04/2016
1	Immunoglobulins (Immunoglobulin)IBA 04/2016
1	Receptor for Advanced Glycation End ProductsIBA 01/2016
1	erastinIBA 01/2016
1	Kelch-Like ECH-Associated Protein 1IBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	quinone (benzoquinone)IBA 01/2016
1	Buthionine SulfoximineIBA 01/2016
1	Ferritins (Ferritin)IBA 01/2016
1	Heme Oxygenase-1IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2014
1	Amylases FDA Link 04/2014

Therapy/Procedure

2	Therapeutics 10/2020 - 01/2018
1	Immunotherapy 01/2021